Recursion Pharmaceuticals (NASDAQ:RXRX) Issues Quarterly Earnings Results
Recursion Pharmaceuticals (NASDAQ:RXRX - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.30) by $0.08. Recursion Pharmaceuticals had a negative net margin of 863.37% and a negative return on...